Antivenoms Global Market Insights and Outlook 2024-2030: A $2.3 Billion Opportunity with Snake Antivenoms Accounting for ~87% Share of the Total Market - BTG PLC Leads the Competition, Followed by CSL Ltd.
July 18, 2024 09:08 ET
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Antivenoms - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antivenoms is...
Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference
July 16, 2024 07:30 ET
|
Evaxion Biotech
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art...
Cancer Immunotherapy Market Size to Reach US$ 412.8 Billion, with Growing CAGR of 10% By 2034
July 11, 2024 08:43 ET
|
FACT.MR
Rockville, MD, July 11, 2024 (GLOBE NEWSWIRE) -- The global cancer immunotherapy market size is approximated at a value of US$ 159.2 billion in 2024 and is foreseen to increase at a CAGR of 10% to...
Vaxcyte Appoints John Furey to Board of Directors
July 02, 2024 08:30 ET
|
Vaxcyte, Inc.
Vaxcyte appoints John Furey to Board of Directors.
Global Vaccine Partnering Deals Analysis Report and Directory 2016-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area
June 25, 2024 11:22 ET
|
Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Vaccine Collaboration and Licensing...
AstriVax enters clinical phase with its novel vaccine platform technology
June 24, 2024 01:00 ET
|
AstriVax
The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with AstriVax technology. The study will also provide...
Vaccine Contract Manufacturing Market Report 2024-2030: Discover the Trends and Drivers Shaping the Global Landscape
June 17, 2024 04:20 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Vaccines (Monovalent, Multivalent) Market Research Report 2024-2028: $94.9 Billion Market Analysis by Technology, Disease, Route of Administration
June 05, 2024 04:25 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease...
Global Anti-Venom Market Report 2024-2032, by Species, Anti-venom Type, Mode of Action, End User and Region - A $2 Billion Market by 2032
June 04, 2024 12:37 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-Venom Market Report by Species, Anti-venom Type, Mode of Action, End User, and Region 2024-2032" report has been added to ...
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
May 31, 2024 04:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...